ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,258.61
-0.40%
Dow Jones
44,860.31
0.28%
Gold vs US Dollar
2,640.515
0.31%
Brent Oil
72.355
-0.13%
Bitcoin
92,899.09
1.01%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. Appili Therapeutics Inc (APLI) Share Price

APLI Appili Therapeutics Inc

0.04
0.005 (14.29%)
26 Nov 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Appili Therapeutics Inc TSX:APLI Toronto Stock Exchange Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.005 14.29 0.04 0.03 0.04 0.04 0.035 0.04 19,000 18:59:50   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 6.69M -3.78M -0.0312 -1.28 4.24M
 Type  Size  Price  Time  Units 
  1,000 0.04 18:59:50 CAD
 
Recent News
DateTimeSource
HeadlineMore APLI News
19/11/202412:17GLOBEAppili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc.
14/11/202412:15GLOBEAppili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
08/11/202413:30BWAditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
07/11/202413:30BWAditxt’s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
06/11/202422:55GLOBEAppili Therapeutics Announces Results of Special Meeting of Shareholders
06/11/202413:30BWAditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem
31/10/202417:00APSBiopharma Bucking Market Trends on Positive FDA Feedback
Period
Draw mode


Loading Follow Feed...

Latest Appili Therapeutics Inc Articles

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Level 2 Lite

1 year 35%, 2 years 45% and *3 years 60%

*Across 3 years £2132.64 only £853.06